PACS Taps Ex-FBI Lawyer as Insiders Cash Out $43M
PACS Group appointed a new legal chief — formerly of General Electric and the FBI — on September 18, 2026, even as its CEO, COO, and a 10% director sold a combined $43.38 million in stock over the pri
PACS Taps Ex-FBI Lawyer as Insiders Cash Out $43M
NEW YORK, October 4 —
Three consecutive earnings beats and a $59 analyst price target tell one story about PACS Group, Inc. (PACS); $43.38 million in insider sales over 90 days, with zero purchases, tell another. The new legal chief, a General Electric and FBI veteran, stepped in September 18 as Morningstar asked whether those sales breached fiduciary duties.
- Most recent quarter: EPS of beat consensus of by 12.5%; three straight quarterly positive surprises through Q2 2026.
- CEO Jason Murray sold across 20+ open-market transactions; Director Mark Hancock sold roughly $12.7 million across two days.
- Analyst consensus price target: $59. Current price: $42.85. Short interest: 7.7% of float.
The $43 Million Exit
Co-founder and CEO Jason Murray executed more than 20 open-market sales between August 17 and September 14, at prices from $42.35 to $45.23, in the company he co-founded in 2013 to operate skilled nursing, assisted living, and independent living facilities nationwide, employing roughly 47,000 people in the senior care sector. Director and 10% holder Mark Hancock sold $6.13 million in a single September 14 transaction, then three more tranches totaling approximately $6.6 million the following day. COO Joshua Jergensen added $1.73 million on September 16. The Form 4 record for the period: $43.38 million out, zero in.
Why the Beats Sharpen the Question
The earnings record gives the gap its edge. The most recent quarter delivered a 12.5% EPS beat; the one before that, 56.5%; the one before that, 26.4%. Trailing twelve-month revenue came in at $5.55 billion, up 9.1% year over year, with free cash flow of $378 million and $3.40 billion in total debt. Analysts with a consensus target of $59 are pricing in a business outperforming its sector. If that assessment is correct, management sold at roughly a 27% discount to its own company's assessed value. A DCF calculator is one way to test whether the implied growth justifies the target.
| Ticker | Mkt cap | Fwd P/E | 52-wk |
|---|---|---|---|
| PACS | $6.8B | 15.8x | +209.4% |
| BTSG | $11.9B | 26.4x | +108.7% |
| SEZL | $3.6B | 16.2x | +24.4% |
| ULS | $13.3B | 25.4x | -10.6% |
| LOAR | $5.8B | 38.2x | -21.7% |
| CGON | $6.0B | n/a | +76.7% |
The Legal Hire and the Next Checkpoint
Per the September 21 8-K, PACS Group appointed a new principal officer, disclosing that the incoming legal chief spent approximately 20 years at General Electric and previously worked for the FBI. Neither background is typical for a skilled nursing operator, and the filing offers no strategic rationale for the hire. The next earnings report is the nearest checkpoint: if EPS continues to beat consensus, the argument that insiders were simply wrong about valuation gains credibility. If a miss materializes, the sustained selling pattern carries a different weight. Run the free PACS Group, Inc. deep-dive →
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
PACS Group appointed a new legal chief — formerly of General Electric and the FBI — on September 18, 2026, even as its CEO, COO, and a 10% director sold a combined $43.38 million in stock over the prior 90 days with zero insider purchases. Morningstar has since published analysis asking whether those sales breached insider fiduciary duties.